🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareHow I handle injection day travel — looking for input Page 2

How I handle injection day travel — looking for input

wendy_avl Tue, Feb 11, 2025 at 10:31 PM 17 replies 1,653 viewsPage 2 of 4
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Feb 13, 2025 at 7:34 AM#6
COA_Karl said:
The gap between trial results and real-world results is consistent and it is not fraud.

I read this differently from COA_Karl, on substance rather than tone. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

9 12pete_manc_UK, anna.melb_AU, mark_tokyo and 6 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Feb 13, 2025 at 8:46 PM#7
wendy_avl said:
My own curve sits about four points below the published mean and I spent two months assuming that meant something was wrong with me or with my…

Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to:

  1. Point estimate (HR/RR/OR) — center of the diamond
  2. Confidence interval width — precision of the estimate
  3. I² statistic — heterogeneity across studies
  4. Individual study weights — are results driven by one large trial?
  5. Prediction interval — range of plausible true effects in future settings

The the trial evidence meta-analysis shows a pooled RR of 0.77 (95% CI 0.68-0.87), I²=35%. This is a robust and consistent effect.

10 13Dr.PulmRoch, maya_sedona, stefan_berlin and 7 others
Reply Quote Save Share Report
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Feb 14, 2025 at 9:58 AM#8
Dr.RaviCardio said:
I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them.

Propensity score matching studies and the trial evidence: when RCTs aren't available for a specific question, propensity score-matched observational studies can provide useful evidence.

A recent PSM study of 12,000 GLP-1 users vs matched controls showed reduced stroke risk (HR 0.82) over 3 years of follow-up[1].

These results complement the RCT data and suggest the benefits translate to real-world populations.

References:
[1] Registry-based cohort study, pre-print 2024.
11 14FranDenver, Dr.BariatricHTX, LindaRN_retired and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
nancy_portland
Member
345
1,567
Aug 2024
Portland, ME
Feb 14, 2025 at 11:09 PM#9

One thing that is still open after SkepticalSean’s answer:

What did you change at the same time, and can you separate the two now?

Last edited: Feb 15, 2025 at 12:09 AM
12 15Dr.PeteFamMed, claudia_zurich, nancy_portland and 9 others
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Feb 17, 2025 at 2:26 PM#10

Closing the loop on my own question.

Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have. That was reassuring rather than otherwise.

40 15RickReta_CO, PharmHunterJen, TomTeleRx and 37 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register